Foreign facilities failed FDA GMP inspections at up to 1.8x the U.S. rate. Journal of Pharmaceutical Innovation study ...
COPENHAGEN, March 10 (Reuters) - Novo Nordisk said on Tuesday it had received a warning letter from the U.S. Food and Drug ...
The Food and Drug Administration is developing a plan to shift more food safety inspection responsibility to state agencies over the course of five years, according to two sources familiar with ...
The US FDA has completed an inspection of Lupin’s Ankleshwar manufacturing facility conducted from March 2 to March 7, 2026, and issued a Form 483 with two observations. The company said it will ...
Novo had announced last month that it was suing Hims to stop it from selling copycat “compounded” versions of Novo’s weight loss and diabetes drugs, Wegovy and Ozempic. Separately, the Food and Drug ...